Showing results (291-300 of 536) with videos related to

Sort By:
Pageof 54
Diabetes Care|September 28, 2006
Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetesWolfgang C Winkelmayer, Zhongxin Zhang, Shahnaz Shahinfar, et al.
Endocrine Connections|May 9, 2023
SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative reviewMerlin C Thomas, Brendon L Neuen, Stephen M Twigg, et al.
Diabetes Care|June 6, 2025
Kidney Disease: The Forgotten Legacy of Type 1 DiabetesMerlin C Thomas, Sophia Zoungas, Nordin M J Hanssen, et al.
Diabetes|March 30, 2004
Improved islet morphology after blockade of the renin- angiotensin system in the ZDF ratChristos Tikellis, Peter J Wookey, Riccardo Candido, et al.
Kidney International. Supplement|October 16, 2004
The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetesJosephine M Forbes, Merlin C Thomas, Suzanne R Thorpe, et al.
The Medical Journal of Australia|August 9, 2006
The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)Merlin C Thomas, Andrew J Weekes, Olivia J Broadley, et al.
Kidney International|July 9, 2003
Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetesJie Qin, Zhili Zhang, Jie Liu, et al.
American Journal of Nephrology|June 17, 2010
Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathyVicki Thallas-Bonke, Melinda T Coughlan, Leon A Bach, et al.
Antioxidants & Redox Signaling|February 25, 2016
Diabetes and Kidney Disease: Role of Oxidative StressJay C Jha, Claudine Banal, Bryna S M Chow, et al.
The American Journal of Pathology|August 26, 2003
Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietinStella Sarlos, Bishoy Rizkalla, Christina J Moravski, et al.
Pageof 54